Neuronetics, Inc.
STIMNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for STIM. That does not mean none is planned.
Get an email about STIM's next catalysts
Track Neuronetics (STIM) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 2 past
No catalysts found.
Market Overview
Stock performance and key metrics
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
WebsiteNo drugs found in this phase.
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
When is Neuronetics, Inc.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for Neuronetics, Inc. (STIM) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track STIM biotech catalysts?β
Add STIM to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Neuronetics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
